(Q53604826)
Statements
Combined use of MRI and PET to monitor response and assess residual disease for locally advanced breast cancer treated with neoadjuvant chemotherapy. (English)
Constance D Lehman
Xiaoming Chen
Mark O Moore
David A Mankoff
Thomas J Lawton
Sue Peacock
Erin K Schubert
Robert B Livingston
1 October 2004
11
10
1115-1124